000026233 000__ 01462cam\a2200493\i\4500
000026233 001__ 26233
000026233 003__ SzGeWIPO
000026233 005__ 20240708162356.0
000026233 008__ 080111s2010    nju|||||r|||| 00| 0 eng d
000026233 035__ $$a(wipo)0
000026233 035__ $$a(OCoLC)1158225036
000026233 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000026233 041__ $$aeng
000026233 050_4 $$aK1401.A15$$bJ68
000026233 08204 $$a346.048$$220
000026233 084__ $$aCH 51
000026233 1001_ $$aOguamanam, Chidi.
000026233 24510 $$aPatents and pharmaceutical R&D :$$bconsolidating private-public partnership approach to global public health crises.
000026233 264_1 $$aHoboken, New Jersey :$$bJohn Wiley & Sons, Inc.,$$c2010.
000026233 300__ $$a1 volume ([25] pages) ;$$c[28] cm.
000026233 336__ $$atext$$btxt$$2rdacontent
000026233 337__ $$aunmediated$$bn$$2rdamedia
000026233 338__ $$avolume$$bnc$$2rdacarrier
000026233 4901_ $$aThe Journal Of World Intellectual Property,$$x1422-2213 ;$$v2010, Vol 13, No 4, pages 556-580
000026233 650_0 $$aPatents (International law)
000026233 650_0 $$aIntellectual property (International law)
000026233 650_0 $$aCopyright, International.
000026233 650_0 $$aDispute resolution (Law)$$zCanada.
000026233 650_0 $$aPatents.
000026233 650_0 $$aIntellectual property.
000026233 650_4 $$aPharmaceuticals
000026233 650_4 $$aAccess to medicine
000026233 650_4 $$aPatents
000026233 650_4 $$aResearch and development (R&D)
000026233 650_6 $$aPropriété intellectuelle (Droit international)
000026233 650_6 $$aDroit d'auteur international.
000026233 650_6 $$aBrevets d'invention$$xDroit international.
000026233 8564_ $$uhttp://onlinelibrary.wiley.com/doi/10.1111/j.1747-1796.2010.00396.x/pdf$$y[Access for WIPO staff only]
000026233 903__ $$aThe Journal of World Intellectual Property.
000026233 904__ $$aJournal article
000026233 942__ $$cART$$2ddc
000026233 952__ $$w2010-12-14$$p2010-0965$$u40465$$bMAIN$$10$$kCH 51$$v2010-12-14$$zLibrary$$71$$cLibrary
000026233 980__ $$aBIB
000026233 999__ $$c28622$$d28622